minigrant3636737552297461989

The NDTA awards up to $10,000 each year for one to two research projects.  The goal is to fund studies that investigate the Neuro-Developmental Treatment approach with either adult or pediatric populations. 

General Guidelines:  $10,000 allocation to one to two projects to be conducted over the course of one year.  Applications must be submitted no later than January 15, 2019. Announcement of award recipients will be made by April 15, 2019 with start date of June 1, 2019.   Application guidelines should be carefully reviewed and followed for fairness of all potential recipients. Any questions concerning the application or guidelines should be addressed to Kathy Dieruf from the NDTA Research Committee at Kdieruf@salud.unm.edu. 

Purpose:  The NDTA research grant awards are provided for studies that investigate the Neuro-Developmental Treatment© (NDT) approach with pediatric and/or adult populations by: A. advancing knowledge and understanding of NDT; B. determining the efficacy or effectiveness of NDT-based interventions; or C. validating the clinical hypotheses and techniques associated with NDT.  Studies may be quantitative, qualitative or mixed methodolgy. 

Budget:  Maximum allowable per study is $10,000; proposals that budget for lesser amounts will be considered. Examples of how the funds could be used include:  (1) research equipment, (2) supplies needed to complete the project, such as small supplies or computer software; (3) subject reimbursement; (4) consultants for research methods or analysis; (5) assistance with writing for publication. Money cannot be used towards travel except to conduct the research. 

Purchase of Equipment:  The NDTA reserves the right to keep any equipment where the purchase costs exceed $1000.

Dissemination:  Grant recipients are strongly encouraged to submit a paper based on the study to a peer-reviewed journal.  They are also responsible for disseminating the results of the study via an article in the NDTA newsletter, and a poster/short presentation at an NDTA conference, the latter is recommended but not required.  

Review process:  All applications will be reviewed by the NDTA Research Committee.  All studies involving human subjects must be approved by a Human Subjects Review Committee through the mechanism at the applicant’s facility and evidence of compliance to HIPAA guidelines must be given prior to release of funds.

To apply for the NDTA grant, please review the Grant Announcement and download and complete the Research Proposal Form. After completing your application, create a separate blinded application file.  When preparing your blinded application file, be sure to black out all names, institutions, locations, and any other information that may identify the grant applicants. Email both the original and the blinded documents in pdf format.  Applications will be reviewed by two blinded reviewers. 

To be considered for the 2018/2019 grant cycle, applications must be emailed to minigrant@ndta.org by January 15, 2019.  For specific questions, please contact Kathy Dieruf from the NDTA Research Committee at Kdieruf@salud.unm.edu.   



NDTA™ Neuro-Developmental Treatment Association 

1540 S. Coast Highway, Ste 204
Laguna Beach, CA 92651 

Phone: 800-869-9295 Fax: 949-376-3456